Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milton EssexWAR:MTN -1.36%29 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:MTN with a GF Score™ of 29/100 and a GF Value™ of zł0.13 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Milton Essex ranks worse than 100% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Milton Essex's Free Cash Flow for the
three
months ended in Mar. 2026 was zł-0.12 Mil. Milton Essex's Revenue for the
three
months ended in Mar. 2026 was zł0.00 Mil. Therefore, Milton Essex's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Milton Essex's FCF Margin % or its related term are showing as below:
WAR:MTN'
s FCF Margin % Range Over the Past 10 Years
Min: -214800 Med: -1335.66 Max: 1300
Current: -214800
During the past 8 years, the highest FCF Margin % of Milton Essex was 1300.00%. The lowest was -214800.00%. And the median was -1335.66%.
WAR:MTN's FCF Margin % is ranked worse than 100% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.55
vs WAR:MTN: -214800.00
Milton Essex FCF Margin % Related Terms
Milton Essex FCF Margin % Historical Data
* Premium members only.
The historical data trend for Milton Essex's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Milton Essex's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milton Essex FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milton Essex's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Milton Essex's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milton Essex (WAR:MTN) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Milton Essex and its competitors. According to the industry distribution chart, Milton Essex ranks #816 out of 816 companies in the Medical Devices & Instruments industry.
Is Milton Essex's FCF Margin % too high?
Milton Essex's current FCF Margin % is 0.00%. Based on the distribution chart, Milton Essex ranks #816 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Milton Essex has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Milton Essex's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Milton Essex ranks #816 out of 816 companies for FCF Margin %. This places Milton Essex in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Milton Essex and its competitors. Milton Essex's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milton Essex stock overvalued right now?
Based on GuruFocus' analysis, Milton Essex (WAR:MTN) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.13, compared to a current price of zł0.73 — trading 457.7% above its estimated fair value. The current FCF Margin % is 0.00%. Milton Essex's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Milton Essex (WAR:MTN), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milton Essex (WAR:MTN) Overvalued in 2026?
Based on GuruFocus' analysis, Milton Essex stock appears to be overvalued.
The current stock price of zł0.73 is trading 457.7% above its estimated GF Value™ of zł0.13.
GuruFocus considers Milton Essex to be Significantly Overvalued.
Key valuation signals for WAR:MTN:
FCF Margin %: 0.00%
GF Value™: zł0.13 vs. price of zł0.73 (457.7% above fair value)
No single metric tells the full story. See the WAR:MTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milton Essex SA provides contact-free hybrid scanners for allergology and oncological dermatology. The products of the company include Ski Sense, FaceCov and InfraSkin.
29GF Score
Get the complete analysis for WAR:MTN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MTN has been successfully added to your 
